Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Journal of Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rollins, D. E.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Drug Testing in Athletes at the 2002 Olympic Winter Games

Douglas E. Rollins, MD, PhD

University of Utah Health Sciences Center, Center for Human Toxicology, 20 South 2030 East, Room 490, University of Utah, Salt Lake City, UT 84112, rollinsdoug{at}hotmail.com

During the 2002 Olympic Winter Games at Salt Lake City, Utah, more athletes tested positive for doping than in all previous Olympic Winter Games combined. Approximately 4% (96) of all registered athletes were tested in the out-of-competition testing phase. There were no positive urine specimens. During the in-competition urine doping control program, 559 urine specimens were tested. There were 2 specimens positive for nandrolone and 1 specimen positive for methamphetamine. During the testing of endurance athletes for erythropoietin and related substances, there were 3 specimens positive for darbepoetin, a substance related to erythropoietin. These results signal an increased awareness of new scientific technologies and a resolve to use these procedures for antidoping efforts. The World Anti-Doping Agency is positioned to take a leadership role in harmonizing the antidoping efforts of the international sport federations, the national Olympic committees, the International Olympic Committee, the national sport governing bodies, and national antidoping agencies.

Key Words: Doping control • drug testing • Olympic Games.

Journal of Pharmacy Practice, Vol. 16, No. 1, 15-21 (2003)
DOI: 10.1177/0897190002239632


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement